Newborn screening for haemoglobinopathies: the Brussels experience

J Med Screen. 1999;6(1):11-5. doi: 10.1136/jms.6.1.11.

Abstract

Objectives: To determine the prevalence of haemoglobinopathies and the need for neonatal screening for haemoglobinopathies in Brussels.

Methods: Between December 1994 and June 1998 23,136 cord blood samples obtained in eight hospital nurseries of Brussels were systematically screened for haemoglobinopathies by isoelectric focusing.

Results: 45% of the newborns were from regions at risk for haemoglobinopathies. Sickle cell disease was diagnosed for 11 neonates (0.048%) and beta thalassaemia major for one neonate. Three hundred and fifty neonates (1.5%) were carriers for a haemoglobin variant, and Hb Bart's was found in 672 cases (2.9%). These prevalences are similar to those reported elsewhere in northern Europe.

Conclusions: These results confirm the value of universal screening for haemoglobinopathies in Brussels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anemia, Sickle Cell / diagnosis
  • Anemia, Sickle Cell / epidemiology
  • Belgium / epidemiology
  • Europe / epidemiology
  • Fetal Blood
  • Hemoglobinopathies / diagnosis*
  • Hemoglobinopathies / epidemiology
  • Hemoglobins, Abnormal / analysis
  • Humans
  • Infant, Newborn
  • Isoelectric Focusing
  • Mass Screening*
  • Prevalence
  • beta-Thalassemia / diagnosis
  • beta-Thalassemia / epidemiology

Substances

  • Hemoglobins, Abnormal
  • hemoglobin Bart's